JACK L. BOWMAN, Chairman and Chief Executive Officer of NeoRx
Corporation, was appointed Executive Chairman and Chairman of the Board
of Directors of NeoRx in March 2003, having served as a Director of
NeoRx since 1994. Mr. Bowman was Company Group Chairman of Johnson &
Johnson, with global responsibility for most of the company’s
pharmaceuticals and diagnostics businesses, from 1987 until his
retirement in 1993. Prior to joining Johnson & Johnson, he was President
of Lederle Laboratories and Corporate Executive Vice President of
American Cyanamid. Previously, he held a range of sales, marketing and
general management positions with Ciba-Geigy. Mr. Bowman is a Director
of Cell Therapeutics, Inc., Celgene Corp., Targeted Genetics Corp.,
Cellegy Pharmaceuticals, Inc., and Reliant Pharmaceuticals and is an
advisor to Bay City Capital LLC. He holds a BEd degree from Western
Washington University.
Jack Bowman - Neorx Corporation (nerx)
October 17, 2003
Jack Bowman - Neorx Corporation (nerx)
July 28, 2003